Home/Filings/4/0001181431-12-064662
4//SEC Filing

HA NGOC TUAN 4

Accession 0001181431-12-064662

CIK 0001325879other

Filed

Dec 13, 7:00 PM ET

Accepted

Dec 14, 8:11 AM ET

Size

9.6 KB

Accession

0001181431-12-064662

Insider Transaction Report

Form 4
Period: 2012-12-12
HA NGOC TUAN
DirectorChief Executive Officer
Transactions
  • Purchase

    Common Stock

    2012-12-12$6.61/sh+60,900$402,318300,540 total
  • Other

    Common Stock

    2012-09-14+33,793239,640 total
  • Other

    Common Stock

    2012-09-1433,793118,187 total(indirect: Held by GRAT)
  • Purchase

    Common Stock

    2012-12-13$6.85/sh+14,100$96,637314,640 total
Footnotes (4)
  • [F1]The increase of shares of directly held common stock was due to a distribution from the Tuan Ha-Ngoc 2009 GRAT to the reporting person on September 14, 2012.
  • [F2]Includes 1208 shares acquired on June 30, 2012 under the AVEO Pharmaceuticals, Inc. Employee Stock Purchase Plan.
  • [F3]The decrease of shares of indirectly held common stock was due to a distribution from the Tuan Ha-Ngoc 2009 GRAT to the reporting person on September 14, 2012.
  • [F4]Shares are held by Gabriel Schmergel, Trustee, or his successor in trust, of the Tuan Ha-Ngoc 2009 GRAT. Mr. Schmergel is trustee of the Tuan Ha-Ngoc 2009 GRAT and he exercises sole voting and investment power over the shares held of record by such trust. Mr. Ha-Ngoc disclaims beneficial ownership over all such shares, except to the extent of his pecurniary interest therein.

Issuer

AVEO PHARMACEUTICALS INC

CIK 0001325879

Entity typeother

Related Parties

1
  • filerCIK 0001241221

Filing Metadata

Form type
4
Filed
Dec 13, 7:00 PM ET
Accepted
Dec 14, 8:11 AM ET
Size
9.6 KB